PRACTICAL AND PSYCHOLOGICAL DIFFICULTIES EXPERIENCED BY PATIENTS WITH HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (HATTR) IN ITALY: PRELIMINARY RESULTS FROM THE TELETHON GUP 15010 STUDY

被引:0
|
作者
Magliano, L. [1 ]
Citarelli, G. [1 ]
Obici, L. [2 ]
Sforzini, C. [2 ]
Di Buduo, E. [2 ]
Sabatelli, M. [3 ]
Luigetti, M. [3 ]
Bisogni, G. [3 ]
Grandis, M. [4 ]
Gemelli, C. [4 ]
Fabrizi, G. [5 ]
Cavallaro, T. [5 ]
Pareyson, D. [6 ]
Fenu, S. [6 ]
Santoro, L. [7 ]
Manganelli, F. [7 ]
Mauro, A. [8 ]
Pradotto, L. [9 ]
Antonini, G. [10 ]
Leonardi, L. [10 ]
Vanoli, F. [10 ]
Russo, M. [11 ]
Stancanelli, C. [11 ]
Mazzeo, A. [12 ]
Vita, G. [12 ]
机构
[1] Univ Campania, Dept Psychol, Caserta, Italy
[2] IRCCS Policlin San Matteo, Amyloidosis Res & Treatment Ctr, Pavia, Italy
[3] Policlin A Gemelli Fdn, Dept Geriatr Neurosci & Orthoped, Rome, Italy
[4] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Maternal, Genoa, Italy
[5] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy
[6] Fdn IRCCS Ist Neurol Carlo Besta, Milan, Italy
[7] Univ Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Naples, Italy
[8] Univ Torino, Dipartimento Neurosci Rita Levi Montalcini, Turin, Italy
[9] IRCCS, Ist Auxol Italiano, Div Neurol & Neuroriabilitaz, Osped S Giuseppe, Oggebbio, VB, Italy
[10] Sapienza Univ Roma, Osped St Andrea, Dip NESMOS, Rome, Italy
[11] Nemo Sud Clin Ctr, Messina, Italy
[12] Univ Messina, Unit Neurol & Neuromuscular Dis, Dept Clin & Expt Med, Messina, Italy
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S30 / S30
页数:1
相关论文
共 50 条
  • [41] PRIMARY RESULTS FROM APOLLO-B, A PHASE 3 STUDY OF PATISIRAN IN PATIENTS WITH TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH CARDIOMYOPATHY
    Longhi, Simone
    Maurer, Mathew S.
    Fontana, Marianna
    Berk, John L.
    Gustafsson, Finn
    Simoes, Marcos
    Grogan, Martha
    Fernandes, Fabio
    Gottlieb, Robert L.
    Kubanek, Milos
    Poulsen, Steen
    Damy, Thibaud
    Diemberger, Igor
    Tahara, Nobuhiro
    Yu, Wen-chuhg
    Tang, W. H. Wilson
    Obici, Laura
    Gonzalez-duarte, Alejandra
    Sekijima, Yoshiki
    White, Matthew T.
    Yureneva, Elena
    Jay, Patrick Y.
    Vest, John
    Gillmore, Julian D.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
  • [42] Primary Results From Apollo-B, A Phase 3 Study Of Patisiran In Patients With Transthyretin-Mediated Amyloidosis With Cardiomyopathy
    Maurer, Mathew S.
    Fontana, Marianna
    Berk, John
    Gustafsson, Finn
    Simoes, Marcus
    Grogan, Martha
    Fernandes, Fabio
    Gottlieb, Robert L.
    Kubanek, Milos
    Poulsen, Steen
    Damy, Thibaud
    Diemberger, Igor
    Tahara, Nobuhiro
    Yu, Wen-Chung
    Tang, W. H. Wilson
    Obici, Laura
    Gonzalez-Duarte, Alejandra
    Sekijima, Yoshiki
    White, Matthew T.
    Arum, Seth
    Jay, Patrick Y.
    Vest, John
    Gillmore, Julian D.
    JOURNAL OF CARDIAC FAILURE, 2023, 29 (04) : 550 - 550
  • [43] PRIMARY RESULTS FROM APOLLO-B OPEN-LABEL EXTENSION STUDY OF PATISIRAN IN PATIENTS WITH TRANSTHYRETIN CARDIAC AMYLOIDOSIS
    Longhi, S.
    Mauer, M.
    Berk, J.
    Hanna, M.
    Gillmore, J.
    Vellosa-schwartzmann, P.
    Lairez, O.
    Hatano, M.
    Cho, H.
    van der Meer, P.
    White, M.
    Yureneva, E.
    Sweetser, M.
    Jay, P.
    Vest, J.
    Fontana, M.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2024, 26 : ii2 - ii2
  • [44] Impact of Patisiran on Norfolk Quality of Life Questionnaire Diabetic Neuropathy (QOL-DN) in patients with Hereditary transthyretin-mediated Amyloidosis: results from the Phase-3 APOLLO study
    Obici, L.
    Coelho, T.
    Adams, D.
    Gonzalez-Duarte, A.
    O'riordan, W.
    Yang, C. -C.
    Yamashita, T.
    Kristen, A.
    Tournev, I.
    Schmidt, H.
    Berk, J.
    Lin, K. -P.
    Gandhi, P.
    Sweetser, M.
    Chen, J.
    Goyal, S.
    Gollob, J.
    Suhr, O.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 459 - 459
  • [45] Long-Term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: 2-year results from the NEURO-TTR open-label extension study
    Brannagan, T.
    Waddington Cruz, M.
    Wang, A. K.
    Polydefkis, M. J.
    Dyck, P. J.
    Khella, S.
    Plante-Bordeneuve, V.
    Berk, J. L.
    Barroso, F.
    Merlini, G.
    Conceicao, I.
    Hughes, S. G.
    Kwoh, J.
    Jung, S. W.
    Guthrie, S.
    Pollock, M.
    Benson, M. D.
    Gertz, M.
    Coelho, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 92 - 92
  • [46] APOLLO-B, a Study of Patisiran in Patients With Transthyretin Cardiac Amyloidosis: Primary LongTerm Results From the Open-Label Extension Period
    Hung, Rebecca R.
    Correia, Edileide D.
    Berk, John L.
    Drachman, Brian
    Fontana, Marianna
    Gillmore, Julian D.
    Mesquita, Claudio T.
    Simoes, Marcus V.
    Yureneva, Elena
    White, Matthew T.
    Sweetser, Marianne T.
    Jay, Patrick Y.
    Vest, John
    Maurer, Mathew S.
    CIRCULATION, 2023, 148
  • [47] Distress in patients with proven and suspected amyloidosis - preliminary results from a prospective cross-sectional analysis of 35 patients of the ongoing Wuerzburg Amyloidosis Cohort Study (AmyKoS)
    Ihne, S. M.
    Schuett, M.
    Morbach, C.
    Hefner, J.
    Geier, A.
    Sommer, C.
    Zeller, D.
    Csef, H.
    Frantz, S.
    Einsele, H.
    Knop, S.
    Stoerk, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 262 - 262
  • [48] RESULTS FROM APOLLO PHASE III STUDY OF PATISIRAN, THE FIRST APPROVED RNAI THERAPEUTIC, IN HEREDITARY ATTR AMYLOIDOSIS PATIENTS WITH POLYNEUROPATHY.
    Zhang, X.
    Sweetser, M. T.
    Robbie, G. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S31 - S31
  • [49] The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy
    Lorenzoni, Valentina
    Trieste, Leopoldo
    Mosca, Marta
    Convertino, Irma
    Tuccori, Marco
    Lucenteforte, Ersilia
    Ferraro, Sara
    Leonardi, Luca
    Roberto, Giuseppe
    Luciano, Nicoletta
    Blandizzi, Corrado
    Gini, Rosa
    Turchetti, Giuseppe
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 9 - 9
  • [50] LONG-TERM USE OF PATISIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC, IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS: 12 MONTH EFFICACY AND SAFETY FROM GLOBAL OPEN LABEL EXTENSION STUDY
    Gonzalez-Duarte, Alejandra
    Coelho, Teresa
    Adams, David
    Yang, Chih-Chao
    Polydefkis, Michael
    Kristen, Arnt
    Tournev, Ivaylo
    Schmidt, Hartmut
    Berk, John
    Lin, Kon-Ping
    Gandhi, Pritesh
    Sweetser, Marianne
    White, Matthew
    Gollob, Jared
    Suhr, Ole
    MUSCLE & NERVE, 2018, 58 : S51 - S51